Hydrofarm Holdings

HYFM

Market cap $8.59M

Hydrofarm Holdings Group, Inc. (HYFM) came out with a quarterly loss of $3.51 per share versus the Zacks Consensus Estimate of a loss of $3.09. This compares to a loss of $2.6 per share a year ago.

SHOEMAKERSVILLE, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its third quarter ended September 30, 2025.

SHOEMAKERSVILLE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (“CEA”), today announced that it will report third quarter 2025 results on Wednesday, November 12, 2025 before market open.

Marijuana stocks are still in trying to reach better trading levels. This could happen in several ways, one of which is reform, as many are waiting to see what unfolds. In the US, there has been a push for more legal states and the end of cannabis prohibtion. Over the last half-decade, as federal reform has been pushed forward, it has had a positive impact on marijuana stocks.

The U.S. cannabis industry continues to grow rapidly as legalization momentum spreads across new states. According to recent data, the market is projected to exceed $35 billion in annual sales by 2025. Additionally, analysts expect the industry to reach over $70 billion by 2030 as federal reform progresses. Last week, renewed discussions in Congress surrounding cannabis rescheduling lifted investor optimism. The Department of Health and Human Services' recommendation to reclassify cannabis also fueled market speculation. As a result, many ancillary stocks—those supporting growers with equipment, nutrients, and hydroponic systems—saw a spike in trading activity. These companies remain essential for industry expansion, offering investors exposure without the risks of direct plant handling.

SHOEMAKERSVILLE, Pa., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) (“Hydrofarm” or the “Company”) a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (“CEA”), today announced that Chris Yetter has been appointed to serve on the Company's Board of Directors (the “Board”) and the Compensation Committee of the Board, effective October 1, 2025.

Most marijuana stock investors are keeping a core focus on the future. At one point in time, most cannabis stocks had fast turnarounds for making a profit. However, this has not been the case for a long while. In fact, since the pandemic, there has been an overwhelming drop in trading in that sector. Now, with a bigger push for federal reform and other rules and regulatory issues being worked on in the last few months, cannabis stocks have been on the rise.

The U.S. cannabis industry continues to expand, with annual sales expected to surpass 40 billion dollars in 2025. Market forecasts suggest long-term growth as more states approve medical and recreational use. Recent discussions on federal legalization have also reignited investor interest. These developments provide a favorable backdrop for ancillary companies, which support the industry without directly handling cannabis. Because they supply cultivators and dispensaries with essential tools, these businesses often face less regulatory risk.

For cannabis investors, watching the industry's growth brings hope. Especially with how volatile the sector can get, even when public companies do well as a business, it does not resonate in the stock market. In recent news, Q2 earnings have been released for most publicly traded cannabis companies. Some companies have reported that they are still generating decent revenue. For others, beyond showing profitability, more partnerships and deals are being made.

Marijuana stock investors are awaiting to hear what will come of cannabis rescheduling. Historically, when news on the matter is released that shows progress, most cannabis stocks begin to trade up. This is what speculation can do. No one wants to be late to invest or miss the chance to be in an emerging sector. Legal cannabis has been on the rise for many years. Facing many roadblocks and still finds a way to forge ahead.